Spread of resistant bacteria and resistance genes from animals to humans - The public health consequences

Journal of Veterinary Medicine Series B: Infectious Diseases and Veterinary Public Health

Volumn 51, Issue 8-9, 2004, Pages 364-369

  Molbak K ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANIMAL; ANTIBIOTIC RESISTANCE; CAMPYLOBACTER; CONFERENCE PAPER; DRUG EFFECT; FOOD CONTROL; GENETICS; HUMAN; MEAT; MICROBIOLOGY; PUBLIC HEALTH; SALMONELLA;

ANIMALS; ANTI-BACTERIAL AGENTS; CAMPYLOBACTER; DRUG RESISTANCE, BACTERIAL; FOOD MICROBIOLOGY; HUMANS; MEAT; PUBLIC HEALTH; SALMONELLA;

ANIMALIA; BACTERIA (MICROORGANISMS); SALMONELLA;

EID: 9244232370     PISSN: 09311793     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0450.2004.00788.x     Document Type: Conference Paper

References (46)

1. Aarestrup, F. M., A. M. Seyfarth, H. D. Emborg, K. Pedersen, R. S. Hendriksen, and F. Bager, 2001: Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark. Antimicrob. Agents Chemother. 45, 2054-2059.
2. Aarestrup, F. M., C. Wiuff, K. Mølbak, and E. J. Threlfall, 2003: Is it time to change fluoroquinolone breakpoints for Salmonella spp.? Antimicrob. Agents Chemother. 47, 827-829.
3. Aarestrup, F. M., H. Hasman, I. Olsen, and G. Sørensen, 2004: International spread of bla(CMY-2)-mediated cephalosporin resistance in a multiresistant Salmonella enterica serovar Heidelberg isolate stemming from the importation of a boar by Denmark from Canada. Antimicrob. Agents Chemother. 48, 1916-1917.
4. Anderson, E. S., 1968: Drug resistance in Salmonella typhimurium and its implications. Br. Med. J. 3, 333-339.
5. Anderson, A. D., J. M. Nelson, S. Rossiter, and F. J. Angulo, 2003: Public health consequences of use of antimicrobial agents in food animals in the United States. Microb. Drug Resist. 9, 373-379.
6. Bager, F., F. M. Aarestrup, M. Madsen, and H. C. Wegener, 1999: Glycopeptide resistance in Enterococcus faecium from broilers and pigs following discontinued use of avoparcin. Microb. Drug Resist. 5, 53-56.
7. Barza, M., and K. Travers, 2002: Excess infections due to antimicrobial resistance: the 'Attributable Fraction'. Clin. Infect. Dis. 34 (Suppl. 3), S126-S130.
8. van den Bogaard, A. E., N. Bruinsma, and E. E. Stobberingh, 2000: The effect of banning avoparcin on VRE carriage in The Netherlands. J. Antimicrob. Chemother. 46, 146-148.
9. Crump, J. A., T. J. Barrett, J. T. Nelson, and F. J. Angulo, 2003: Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae. Clin. Infect. Dis. 37, 75-81.
10. Dunne, E. F., P. D. Fey, P. Kludt, R. Reporter, F. Mostashari, P. Shillam, J. Wicklund, C. Miller, B. Holland, K. Stamey, T. J. Barrett, J. K. Rasheed, F. C. Tenover, E. M. Ribot, and F. J. Angulo, 2000: Emergence of domestically acquired ceftriaxone-resistant Salmonella infections associated with AmpC beta-lactamase. JAMA 284, 3151-3156.
11. Endtz, H. P., G. J. Ruijs, B. van Klingeren, W. H. Jansen, T. van der Reyden, and R. P. Mouton, 1991: Quinolone resistance in Campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. J. Antimicrob. Chemother. 27, 199-208.
12. Engberg, J., F. M. Aarestrup, D. E. Taylor, P. Gerner-Smidt, and I. Nachamkin, 2001: Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg. Infect. Dis. 7, 24-34.
13. Engberg, J., J. Neimann, E. M. Nielsen, F. M. Aarestrup, and V. Fussing, 2004: Quinolone-resistant Campylobacter infections: risk factors and clinical consequences. Emerg. Infect. Dis. 10, 1056-1063.
14. Fey, P. D., T. J. Safranek, M. E. Rupp, E. F. Dunne, E. Ribot, P. C. Iwen, P. A. Bradford, F. J. Angulo, and S. H. Hinrichs, 2000: Ceftriaxone-resistant Salmonella infection acquired by a child from cattle. N. Engl. J. Med. 342, 1242-1249.
15. Glynn, M. K., V. Reddy, L. Hutwagner, T. Rabatsky-Ehr, B. Shiferaw, D. J. Vugia, S. Segler, J. Bender, T. J. Barrett, and F. J. Angulo, 2004: Prior antimicrobial agent use increases the risk of sporadic infections with multidrug-resistant Salmonella enterica serotype Typhimurium: a FoodNet case-control study, 1996-1997. Clin. Infect. Dis. 38(Suppl 3), S227-S236.
16. Gupta, A., J. Fontana, C. Crowe, B. Bolstorff, A. Stout, S. Van Duyne, M. P. Hoekstra, J. M. Whichard, T. J. Barrett, and F. J. Angulo, 2003: Emergence of multidrug-resistant Salmonella enterica serotype Newport infections resistant to expanded-spectrum cephalosporins in the United States. J. Infect. Dis. 188, 1707-1716.
17. Gupta, A., J. M. Nelson, T. J. Barrett, R. V. Tauxe, S. P. Rossiter, C. R. Friedman, K. W. Joyce, K. E. Smith, T. F. Jones, M. A. Hawkins, B. Shiferaw, J. L. Beebe, D. J. Vugia, T. Rabatsky-Ehr, J. A. Benson, T. P. Root, and F. J. Angulo, 2004: Antimicrobial resistance among Campylobacter strains, United States, 1997-2001. Emerg. Infect. Dis. 10, 1102-1109.
18. Helms, M., P. Vastrup, P. Gerner-Smidt, and K. Mølbak, 2002: Excess mortality associated with antimicrobial drug-resistant Salmonella typhimurium. Emerg. Infect. Dis. 8, 490-495.
19. Helms, M., J. Simonsen, and K. Mølbak, 2004: Quinolone resistance is associated with increased risk of invasive illness and death in Salmonella Typhimurium infection. J. Infect. Dis. (in press).
20. Holmberg, S. D., M. T. Osterholm, K. A. Senger, and M. L. Cohen, 1984a: Drug-resistant Salmonella from animals fed antimicrobials. N. Engl. J. Med. 311, 617-622.
21. Holmberg, S. D., J. G. Wells, and M. L. Cohen, 1984b: Animal-to-man transmission of antimicrobial-resistant Salmonella: investigations of U.S. outbreaks, 1971-1983. Science 225, 833-835.
22. Hummel, R., H. Tschäpe, and W. Witte, 1986: Spread of plasmid-mediated nourseothricin resistance due to antibiotic use in animal husbandry. J. Basic Microbiol. 26, 461-466.
23. Johnson, J. R., 2004: Food-borne Antibiotic Resistant and Pathogenic E. coli. NARMS Scientific Meeting, March 4-5, 2004, Atlanta, GA.
24. Klare, I., D. Badstubner, C. Konstabel, G. Bohme, H. Claus, and W. Witte, 1999: Decreased incidence of VanA-type vancomycin-resistant enterococci isolated from poultry meat and from fecal samples of humans in the community after discontinuation of avoparcin usage in animal husbandry. Microb. Drug Resist. 5, 45-52.
25. Mølbak, K., D. L. Baggesen, F. M. Aarestrup, J. M. Ebbesen, J. Engberg, K. Frydendahl, P. Gerner-Smidt, A. M. Petersen, and H. C. Wegener, 1999: An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype typhimurium DT104. N. Engl. J. Med. 341, 1420-1425.
26. Martin, L. J., M. Fyfe, K. Dore, J. A. Buxton, F. Pollari, B. Henry, D. Middleton, R. Ahmed, F. Jamieson, B. Ciebin, S. A. McEwen, and J. B. Wilson, 2004: Increased burden of illness associated with antimicrobial-resistant Salmonella enterica serotype typhimurium infections. J. Infect. Dis. 189, 377-284.
27. Mateu, E., and M. Martin, 2001: Why is anti-mircrobial resistance a veterinary problem as well? J. Vet. Med. B 48, 569-581.
28. McClellan, J., S. Sossiter, K. Joyce, K. Stamey, A. Anderson, and the NARMS working group, 2002: Prevalence and Consequences of Fluoroquinolone- resistant Campylobacter Infections: NARMS 1997-2000. 3rd International Conference on Emerging Infectious Diseases, March 2002, Atlanta, GA.
29. Mead, P. S., L. Slutsker, V. Dietz, L. F. McCaig, J. S. Bresee, C. Shapiro, P. M. Griffin, and R. V. Tauxe, 1999: Food-related illness and death in the United States. Emerg. Infect. Dis. 5, 607-625.
30. Neimann, J., E. M. Nielsen, J. Engberg, F. M. Aarestrup, K. Mølbak, and H. C. Wegener, 2004: Serotype specific risk factors and clinical presentations of gastrointestinal diseases associated with campylobacteriosis in Denmark. J. Infect. (in press).
31. O'Brien, T. F., 2002: Emergence, spread, and environmental effect of antimicrobial resistance: how use of an antimicrobial anywhere can increase resistance to any antimicrobial anywhere else. Clin. Infect. Dis. 34 (Suppl. 3), S78-S84.
32. Olsen, S. J., E. E. DeBess, T. E. McGivern, N. Marano, T. Eby, S. Mauvais, V. K. Balan, G. Zirnstein, P. R. Cieslak, and F. J. Angulo, 2001: A nosocomial outbreak of fluoroquinolone-resistant Salmonella infection. N. Engl. J. Med. 344, 1572-1579.
33. Pantosti, A., M. Del Grosso, S. Tagliabue, A. Macri, and A. Caprioli, 1999: Decrease of vancomycin-resistant enterococci in poultry meat after avoparcin ban. Lancet 354, 741-742.
34. Smith, K. E., J. M. Besser, C. W. Hedberg, F. T. Leano, J. B. Bender, J. H. Wicklund, B. P. Johnson, K. A. Moore, and M. T. Osterholm, 1999: Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team. N. Engl. J. Med. 340, 1525-1532.
35. Summers, A. O., 2002: Generally overlooked fundamentals of bacterial genetics and ecology. Clin. Infect. Dis. 34 (Suppl. 3), S85-S92.
36. Sundsfjord, A., G. S. Simonsen, and P. Courvalin, 2001: Human infections caused by glycopeptide-resistant Enterococcus spp: are they a zoonosis? Clin. Microbiol. Infect. 7 (Suppl. 4), 16-33.
37. Swartz, M. N., 2002: Human diseases caused by foodborne pathogens of animal origin. Clin. Infect. Dis. 34 (Suppl. 3), S111-S122.
38. Tauxe, R. V., 1999: Salmonella Enteritidis and Salmonella Typhimurium DT104: successful subtypes in the modern world. In: Scheid, W. M., W. A. Craig, and J. M. Hughes (eds), Emerging Infections 3, pp. 37-52. ASM Press, Washington, DC.
39. Threlfall, E. J., 2000: Epidemic Salmonella typhimurium DT 104 - a truly international multiresistant clone. J. Antimicrob. Chemother. 46, 7-10.
40. Unicomb, L., J. Ferguson, T. V. Riley, and P. Collignon, 2003: Fluoroquinolone resistance in Campylobacter absent from isolates, Australia. Emerg. Infect. Dis. 9, 1482-1483.
41. Varma, J. K., K. Mølbak, T. J. Barrett, J. L. Beebe, T. F. Jones, T. Rabatsky-Ehr, K. E. Smith, D. J. Vugia, H. H. Chang, and F. J. Angulo, 2004: Antimicrobial-resistant Nontyphoidal Salmonella is Associated with Excess Bloodstream Infections and Hospitalizations. NARMS Scientific Meeting, March 4-5, 2004, Atlanta, GA.
42. Walker, R. A., A. J. Lawson, E. A. Lindsay, L. R. Ward, P. A. Wright, F. J. Bolton, D. R. Wareing, J. D. Corkish, R. H. Davies, and E. J. Threlfall, 2000: Decreased susceptibility to ciprofloxacin in outbreak-associated multiresistant Salmonella typhimurium DT104. Vet. Rec. 147, 395-396.
43. Winokur, P. L., A. Brueggemann, D. L. DeSalvo, L. Hoffmann, M. D. Apley, E. K. Uhlenhopp, M. A. Pfaller, and G. V. Doern, 2000: Animal and human multidrug-resistant, cephalosporin-resistant Salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamase. Antimicrob. Agents Chemother. 44, 2777-2783.
44. Winokur, P. L., R. Canton, J. M. Casellas, and N. Legakis, 2001a: Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin. Infect. Dis. 32 (Suppl. 2), S94-S103.
45. Winokur, P. L., D. L. Vonstein, L. J. Hoffman, E. K. Uhlenhopp, and G. V. Doern, 2001b: Evidence for transfer of CMY-2 AmpC beta-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans. Antimicrob. Agents Chemother. 45, 2716-2722.
46. Witte, W., 1998: Medical consequences of antibiotic use in agriculture. Science 279, 996-997.